Bookmark
Forward
No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib.
Marianna Politou, Anastasios Karadimitris, Evangelos Terpos, Ioannis Kotsianidis, Jane F Apperley, Amin Rahemtulla
Leukemia research 2006 Feb
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Marianna Politou, Anastasios Karadimitris, Evangelos Terpos, Ioannis Kotsianidis, Jane F Apperley, Amin Rahemtulla.
No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib.
Leukemia research.
2006 Feb;30(2):240-1
Mesh Tags
Aged
Antineoplastic Agents
Boronic Acids
Drug Resistance
Female
Humans
Multiple Myeloma
Mutation
Protease Inhibitors
Proteasome Endopeptidase Complex
Pyrazines
Substances
Antineoplastic Agents
Boronic Acids
Protease Inhibitors
Pyrazines
bortezomib
PSMB5 protein, human
Proteasome Endopeptidase Complex
PMID: 16081156
View Full Text